JEFF Brazier was left visibly squirming in awkward scenes on This Morning as he refused to say a caller's name out loud. The telly presenter, 45, appeared bizarrely hesitant to repeat back the ...

Astrazeneca (AZN) ended the recent trading session at $75.57, demonstrating a +1.79% swing from the preceding day's closing price. This change outpaced the S&P 500's 0.49% gain on the day.

Below is Validea's guru fundamental report for ASTRAZENECA PLC (ADR) (AZN). Of the 22 guru strategies we follow, AZN rates highest using our P/B Growth Investor model based on the published ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The latest trading session saw Astrazeneca (AZN) ending at $77.47, denoting a -0.63% adjustment from its last day's close. The stock outperformed the S&P 500, which registered a daily loss of 1.78%.

UBS analyst Matthew Weston maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of £142.00. The company’s shares opened today at p12,090.00. Easily ...

In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against the other high growth mega cap stocks. Exactly 5 years ago, the world struggled to deal with a ...

(RTTNews) - The Phase III WAYPOINT trial results revealed that AstraZeneca (AZN.L, AZN) and Amgen's (AMGN) TEZSPIRE (tezepelumab-ekko) significantly decreased nasal polyp severity, reduced the ...

Investors in AstraZeneca plc (Symbol: AZN) saw new options become available today, for the May 2nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AZN ...